Immune checkpoints are crucial regulators of the immune system, preventing overactivation that could lead to autoimmunity, but they can also be exploited by cancer cells to evade immune detection. Therapeutic interventions targeting these checkpoints, such as checkpoint inhibitors, have revolutionized cancer treatment by enhancing the immune response against tumors.